Term
Chapter 2 of the ICD-10-CM contains the codes for most ___ and all ___ neoplasms. Certain benign neoplasms, such as ___ ___, may be found in the specific ___ ___ chapters. To properly code a neoplasm it is necessary to determine from the record if the neoplasm is ___, ___, ___, or of ___ histologic behavior. If malignant, any secondary (___) sites should also be determined. |
|
Definition
benign malignant prostatic adenomas body system benign in-situ malignant uncertain metastatic |
|
|
Term
A ___ malignant neoplam that ___ two or more ___ (next to each other) sites should be classified to the subcategory/code .8 ('___ ___'), unless the combination is specifically ___ elsewhere. For multiple neoplasms of the ___ ___ that are not contiguous such as tumors in different ___ of the same ___, codes for ___ ___ should be assigned. |
|
Definition
primary overlaps contiguous overlapping lesion indexed same site quadrants breast each site |
|
|
Term
Malignant neoplasms of ___ tissue are to be coded to the site of ___ mentioned, e.g., ___ pancreatic malignant neoplasms involving the stomach are coded to ___, unspecified (C25.9). |
|
Definition
ectopic origin ectopic pancreas |
|
|
Term
The ___ table in the Alphabetic Index should be referenced ___. However, if the histological term is documented, that ___ should be referenced first, rather than going immediately to the ___ ___, in order to determine which ___ in the Neoplasm Table is appropriate. For example, if the documentation indicates "___," refer to the term in the Alphabetic Index to review the entries under this term and the instructional note to "___ ___ neoplasm, by site, benign." The table provides the proper code based on the ___ of neoplasm and the ___. It is important to select the proper ___ in the table that corresponds to the ___ of neoplasm. The Tabular List should then be referenced to verify that the ___ ___ has been selected from the table and that a ___ ___ site code does not exist. |
|
Definition
neoplasm first term Neoplasm Table column adenoma see also type site column type correct code more specific |
|
|
Term
If the ___ is directed at the malignancy, designate the malignancy as the ___ diagnosis. |
|
Definition
|
|
Term
The only exception of this guideline is if a patient admission/encounter is ___ for the administation of ___, ___ or ___ therapy, assign the appropriate Z51.- code as the first-lister or ___ diagnosis, and the diagnosis or problem for which the ___ is being performed as a ___ diagnosis. |
|
Definition
solely chemotherapy immunotherapy radiation principal service secondary |
|
|
Term
When a patient is admitted because of a primary neoplasm with ___ and treatment is directed toward the ___ site only, the secondary neoplasm is designated as the ___ diagnosis even though the ___ malignancy is still ___. |
|
Definition
metastasis secondary principal primary present |
|
|
Term
When admission/encounter is for management of an ___ associated with the ___, and the treatment is only for ___, the appropriate code for the ___ is sequenced as the principal or first-listed diagnosis followed by the appropriate code for the ___ (such as code D63.0, ___ in neoplastic disease). |
|
Definition
anemia malignancy anemia malignancy anemia Anemia |
|
|
Term
When the admission/encounted is for management of an ___ associated with an ___ ___ of the adminstration of ___ or ___ and the ___ ___ is for the anemia, the anemia code is sequenced ___ followed by the appropriate codes of the ___ and the ___ ___ (T45.1x5, Adverse effect of antineoplastic and immunosuppressive drugs). |
|
Definition
anemia adverse effect chemotherapy immunotherapy only treatment first neoplasm adverse effect |
|
|
Term
When the admission/encounter is for management of an ___ associated with an adverse effect of ___, the anemia code should be sequenced ___, followed by the appropriate ___ code and code Y84.2, Radiological procedure and radiotherapy as the cause of ___ ___ of the patient, or of later complication, without mention of ___ at the time of the procedure. |
|
Definition
anemia radiotherapy first neoplasm abnormal reaction misadventure |
|
|
Term
When the admission/encounter is for management of ___ due to the ___ and only the dehydration is being treated (___ ___), the ___ is sequenced first, followed by the code(s) for the ___. |
|
Definition
dehydration malignancy intravenous rehydration dehydration malignancy |
|
|
Term
When the admission/encounter is for treatment of a ___ resulting from a ___ ___, designate the complication as the ___ or first-listed diagnosis if treatment is directed at ___ the ___. |
|
Definition
complication surgical procedure principal resolving complication |
|
|
Term
When a primary malignancy has been previously ___ or ___ from its site and there is __ ___ ___ directed to that site and there is __ ___ of any exiting ___ malignancy, a code from category Z85, Personal ___ of malignant neoplasm, should be used to indicate the ___ ___ of the malignancy. Any mention of ___, ___, or ___ to another site is coded as a ___ malignant neoplasm to that site. The secondary site may be the ___ or first-listed withe the Z85 code used as a secondary code. |
|
Definition
excised eradicated no further treatment no evidence primary history former site extension invasion metastasis secondary principal |
|
|
Term
When an episode of care involves the ___ ___ of a neoplasm, ___ or ___ site, followed by adjunct ___ or radiation treatment during the ___ episode of care, the code for the ___ should be assigned as ___ or first-listed diagnosis. |
|
Definition
surgical removal primary secondary chemotherapy same neoplasm principal |
|
|
Term
If a patient admission/encounter is solely for the administration of ___, ___ or ___ therapy assign code Z51.0, ___ __ antineoplastic radiation therapy, or Z51.11, Encounter for antinoplastic chemotherapy, or Z51.12, Encounter for antineoplastic immunotherapy as the first-listed or principal diagnosis. If a patient receives ___ ___ ___ of these therapies during the ___ admission ___ ___ ___ of these codes may be assigned, in any ___. The ___ for which the therapy is being administered should be assigned as a ___ diagnosis. |
|
Definition
chemotherapy immunotherapy radiation Encounter for more than one same more than one sequence malignancy secondary |
|
|
Term
When a patient is admitted __ __ ___ __ radiotherapy, immunotherapy, or chemotherapy and develops ___ such as uncontrolled ___ __ ___ or ___, the principal or first-listed diagnosis is Z51.0, ___ __ antineoplastic radiation therapy, or Z51.11, Encounter for antineoplastic chemotherapy, or Z51.12, Encounter for anitneoplastic immunotherapy followed by any codes for the ___. |
|
Definition
for the purpose of complications nausea and vomiting dehydration Encounter for complications |
|
|
Term
When the reason for admission/encounter is to determine the ___ of the ____, or for a procedure such as ___ or ___, the ___ malignancy or appropriate metastatic site is designated as the principal or first-listed diagnosis, ___ ___ chemotherapy or radiotherapy is ___. |
|
Definition
extent malignancy paracentesis thoracentesis primary even though administered |
|
|
Term
Symptoms, ___, and ill-defined ___ listed in Chapter __ characteristic of, or ___ ___, an existing primary or secondary ___ malignancy ___ be used to replace the malignancy as ___ or first-listed diagnosis, regardless of the number of admissions or encounters for ___ ___ ___ of the neoplasm. |
|
Definition
signs conditions 18 associated with site cannot principal treatment and care |
|
|
Term
A patient may have more than one malignant ___ in the same ___. These tumors may represent different ___ or ___ disease, depending on the site. Should the documentation be ___, the provider should be queried as to the ___ of each tumor so that the ___ codes can be assigned. |
|
Definition
tumor organ primaries metastatic unclear status correct |
|
|
Term
Code C80.0, ___ malignant neoplasm, unspecified, is for use ___ in those cases where the patient has advanced ___ disease and no known ___ or ___ sites are specified. It should ___ __ ___ in place of assigning codes for the primary site and __ ___ secondary sites. |
|
Definition
Disseminated only metastatic primary secondary not be used all known |
|
|
Term
Code C80.1, Malignant (___) neoplasm, ___, equateds to Cancer, ____. This code should only be used when __ ___ can be made as to the ___ site of a malignancy. This code should __ be used in the ___ setting. |
|
Definition
primary unspecified unspecified no determination primary rarely inpatient |
|
|
Term
If the ___ for the encounter is for ___ of a primary malinancy, ___ the malignancy as the ___/first-listed diagnosis. The ___ site is to be sequenced ___, followed by any ___ sites. |
|
Definition
reason treatment assign principal primary first metastatic |
|
|
Term
When an encounter is for a primary malignancy with ___ and treatment is ___ toward the metastatic (___) site(s) ___, the metastatic ___(s) is designated as the principal/first-listed diagnosis. The ___ malignancy is coded as an ____ code. |
|
Definition
metastasis directed secondary only site primary additional |
|
|
Term
When a ___ woman has a malignant neoplasm, a code from ___ O9A.1-, Malignant neoplasm complicating ___, ___, and the ___, should be sequenced ___, followed by the appropriate code from Chapter __ to indicate the ___ of neoplasm. |
|
Definition
pregnant subcategory pregnancy childbirth puerperium first 2 type |
|
|
Term
When an encounter is for management of a ___ associated with a ___, such as ___, and the treatment is ___ for the ___, the complication is coded ___, followed by the appropriate code(s) for the ___. |
|
Definition
complication neoplasm dehydration only complication first neoplasm |
|
|
Term
The exception to this guideline is ___. When the admission/encounter is for ___ of an ___ associated with the malignancy, and the treatment is ___ for anemia, the appropriate code for the ___ is sequenced as the principal or first-listed diagnosis followed by code D63.0, ___ in ___ disease. |
|
Definition
anemia management anemia only malignancy Anemia neoplastic |
|
|
Term
When an encounter is for treatment of a ___ resulting from a ___ ___ performed for the treatment of the ___, designate the ___ as the principal/first listed diagnosis. See guideline regarding the coding of a current ___ versus personal ___ to determine if the code for the neoplasm should also be assigned. |
|
Definition
complication surgical procedure neoplasm complication malignancy history |
|
|
Term
When an encounter is for a ___ ___ due to a ___, and the ___ of treatment is the fracture, a code from subcategory M84.5, ___ fracture in neoplastic diease, should be sequenced first, followed by the code for the neoplasm. If the focus of treatment is the ___ with an associated ___ ___, the neoplasm code should be sequenced ___, followed by a code from M84.5 for the ___ ___. |
|
Definition
pathological fracture neoplasm focus Pathological neoplasm pathological fracture first pathological fracture |
|
|
Term
When a primary malignancy has been ___ but further treatment, such as an additional ___ for the malignancy, ___ therapy or ___ is directed to that site, the primary malignancy code should be used until ___ __ ___. |
|
Definition
excised surgery radiation chemotherapy treatment is completed |
|
|
Term
When a primary malignancy has been ___ or ___ from its site, there is __ ___ treatment (of the malignancy) ___ to that site, and there is __ ___ of any existing primary malignancy, a code from category Z85, Personal ___ of malignant neoplasm, should be used to indicate the ___ ___ of the malignancy. |
|
Definition
excised eradicated no further directed no evidence history former site |
|
|
Term
The categories for ___, and category C90, ___ ___ and malignant ___ ___ neoplasms, have codes indicating whether or not the leukemia has achieved ___. There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is ___ as to whether the leukemia has achieved remission, the provider should be ___. |
|
Definition
leukemia Multiple myeloma plasma cell remission unclear queried |
|
|
Term
A malignant neoplasm of a ___ organ should be coded as a transplant ___. Assign first the appropriate code from the category T86.-, Complications of transplanted organs and tissue, followed by code C80.2, Malignant neoplasm associated with transplanted organ. Use additional code for the specific malignancy. |
|
Definition
|
|